Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$115.0M
+26.1% from 2023
Prescriptions
13K
$9,046.65 per claim
Patients
1,505
1,244 prescribers
Total spending, 2024
$115.0M
$76,436.67 per patient
Medicare prescription drug plans paid $115.0M for Rukobia in 2024, for 12,716 prescriptions and refills to 1,505 patients (up 26.1% from 2023). The average cost per claim was $9,046.65.
Florida had the highest Medicare cost for Rukobia in 2024: $19.9M for 2,223 claims, followed by California ($17.1M).
Cyril R Gaultier, infectious disease in Palm Springs, CA, had the highest Medicare cost for Rukobia in 2024: 225 claims costing $2.3M.
Rukobia is made by GSK plc (GSK), listed in the Medicare spending data as Viiv Healthcare.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Cyril R Gaultier Palm Springs, CA | Infectious Disease | 225 | 26 | $2.3M |
| Ruben D Martinez Harlingen, TX | Family Practice | 197 | 39 | $1.7M |
| Cecilia D Aduako |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 823 | 7,433 | 934 | $63.9M |
| 2023 | 1,023 | 9,968 | 1,227 | $91.2M |
| 2024 | 1,244 | 12,716 | 1,505 | $115.0M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Infectious Disease |
| 162 |
| 12 |
| $1.4M |
| Gennady Nosovitsky Cathedral City, CA | Physician Assistant | 113 | 11 | $966K |
| Jeffrey Burack Oakland, CA | Internal Medicine | 125 | 12 | $857K |
| Lee R Liskey San Francisco, CA | Internal Medicine | 94 | Under 11 | $853K |
| Joseph P McGowan Manhasset, NY | Infectious Disease | 97 | Under 11 | $824K |
| Ivan A Guerrero Jacksonville, FL | Infectious Disease | 70 | Under 11 | $689K |
| Noah Lee Oakland Park, FL | Family Practice | 71 | Under 11 | $647K |
| Jihad Slim Newark, NJ | Infectious Disease | 72 | Under 11 | $638K |
| Joseph R Piperato Miami, FL | Internal Medicine | 67 | Under 11 | $590K |
| Mark T Watkins Philadelphia, PA | General Practice | 48 | Under 11 | $537K |
| Matthew Herrmann Los Angeles, CA | Internal Medicine | 59 | Under 11 | $501K |
| David J Surovchak Wilson, NC | Physician Assistant | 61 | Under 11 | $486K |
| Melissa M Stevenson Albany, GA | Nurse Practitioner | 57 | Under 11 | $471K |
| Carlos D Malvestutto Columbus, OH | Infectious Disease | 53 | Under 11 | $468K |
| Shannon K Tyler Mobile, AL | Internal Medicine | 45 | Under 11 | $458K |
| Samit Desai Hackensack, NJ | Infectious Disease | 49 | Under 11 | $457K |
| Martha L Greenwald Indianapolis, IN | Nurse Practitioner | 50 | Under 11 | $451K |
| Clayton O Barbour II Cathedral City, CA | Internal Medicine | 52 | Under 11 | $450K |
| Vanessa I Silebi Miami, FL | Internal Medicine | 47 | Under 11 | $447K |
| Louis J Cubba San Francisco, CA | Internal Medicine | 48 | Under 11 | $438K |
| Ricky K Hsu New York, NY | Internal Medicine | 48 | Under 11 | $428K |
| Jhoana P Quezada El Paso, TX | Nurse Practitioner | 45 | Under 11 | $397K |
| Alan J Stein Brooklyn, NY | Internal Medicine | 45 | Under 11 | $395K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Viiv Healthcare GSK | 12,716 | $115.0M |